Showing results (1721-1730 of 3,526) with videos related to

Sort By:
Pageof 353
Thoracic Cancer|October 31, 2024
Quantitative analysis of imaging characteristics in lung adenocarcinoma in situ using artificial intelligenceWensong Shi, Yuzhui Hu, Yulun Yang, et al.
Thoracic Cancer|October 23, 2024
Implementing the optimized hippo-avoidance prophylactic cranial irradiation for limited-stage small cell lung cancer by tomotherapy and volumetric modulated arc therapyTian-You Zhan, Lei Deng, Wen-Qing Wang, et al.
Thoracic Cancer|May 29, 2026
Heterogeneity of Cancer-Associated Fibroblasts and Precision Targeting Strategies for Cancer TherapyYijie Wang, Guangyao Zhou, Pengpeng Zhang, et al.
Thoracic Cancer|May 12, 2026
Perioperative Normobaric Hyperoxia Combined With Pulmonary Rehabilitation Intervention for Enhanced Short-Term Recovery in Lung Cancer SurgeryMei Zhou, Jiani Liu, Dan Li, et al.
Thoracic Cancer|May 11, 2026
The Efficacy and Safety of Nab-Paclitaxel Plus Anlotinib in Small-Cell Lung Cancer for Second-Line TherapyLi-Jun Tian, Fei-Fei Zhou, Min Dai, et al.
Thoracic Cancer|May 16, 2026
Global Burden of Respiratory Tract Cancers From 1990 to 2021: Systematic Analysis of the Global Burden of Disease Study 2021Yuqing Wang, Yi Yao, Xinchen Sun, et al.
Thoracic Cancer|May 19, 2026
Interstitial Lung Disease in Patients With Unresectable Stage III NSCLC Treated With Chemoradiotherapy Followed by Durvalumab in Japan: Analysis From the Multicenter Prospective AYAME StudyNobuyuki Yamamoto, Hirotsugu Kenmotsu, Kiichiro Ninomiya, et al.
Thoracic Cancer|March 16, 2026
Association of Immune-Related Adverse Events and the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Adjusting for Immortal Time BiasYoshiki Kuwabara, Hiroyuki Ohya, Maiko Osawa, et al.
Thoracic Cancer|March 10, 2026
Disruption of Radiological Surveillance Following a Global Health Crisis in Resected Lung CancerÁlvaro Fuentes-Martín, Néstor J Martínez-Hernández, Raul Embun, et al.
Thoracic Cancer|March 13, 2026
Bridging FDA Adverse Event Reporting System (FAERS) and Clinical Practice: Comprehensive Characterization of Immune Checkpoint Inhibitors Toxicities in Geriatric Lung Cancer PatientsYumeng Tian, Xin Nie, Yue Yuan, et al.
Pageof 353